Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001091803 | SCV001248026 | uncertain significance | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002375013 | SCV002688125 | uncertain significance | Cardiovascular phenotype | 2022-10-26 | criteria provided, single submitter | clinical testing | The c.9206C>T (p.A3069V) alteration is located in exon 27 (coding exon 26) of the TNXB gene. This alteration results from a C to T substitution at nucleotide position 9206, causing the alanine (A) at amino acid position 3069 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002480457 | SCV002781982 | uncertain significance | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2021-07-15 | criteria provided, single submitter | clinical testing |